Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Myeloid-derived suppressor cells (MDSC) are an unusual type of blood cell that is able to potently turn off immune responses. These cells are not normally present in healthy individuals, when a tumour is present, MDSC can block clearance of the tumour by the body’s immune defenses. A better understanding of how MDSC shut down tumour clearance would greatly improve the success of cancer treatments. Unfortunately, MDSC are difficult for scientists to study because there is currently no effective method to isolate them in pure form. The goal of this project is to design highly effective ways of isolating these cells so that they can be studied in the laboratory. The long-term goal is to understand how to turn these cells “off” in tumours so that a patient will be more able to fight their cancer.TO BE CONT’D
Kelly McNagny
STEMCELL Technologies Canada Inc
Life Sciences
Health and Related Sciences & Technology; Biotechnology
The University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.